(Q39635628)
Statements
Efficacy, safety, and immunogenicity of the human papillomavirus 16/18 AS04-adjuvanted vaccine in women older than 25 years: 7-year follow-up of the phase 3, double-blind, randomised controlled VIVIANE study (English)
Suzanne M Garland
M Rowena Del Rosario-Raymundo
Archana Chatterjee
Eduardo Lazcano-Ponce
Céline Bouchard
Mark G Martens
Deborah M Money
Swee Chong Quek
Barbara Romanowski
Bram Ter Harmsel
Kah Leng Fong
Henry Kitchener
Galina Minkina
Yong Kuei Timothy Lim
Tanya Stoney
Nahida Chakhtoura
Margaret E Cruickshank
Alevtina Savicheva
Daniel Pereira da Silva
Murdo Ferguson
Anco C Molijn
Wim G V Quint
Karin Hardt
Dominique Descamps
Pemmaraju V Suryakiran
Naveen Karkada
Brecht Geeraerts
Gary Dubin
VIVIANE Study Group